Melius has received a DIR licence from Australia’s OGTR, a critical regulatory milestone as we advance MMB-003 toward first-in-human clinical trials as a potential therapy for #UlcerativeColitis
Read more: https://t.co/246T71Cq1v
#Microbiome#GutHealth#IBD#Biotech#Innovation
As leaders in the field of microbiome sciences and gut-brain interactions, we are so grateful to have both Dr. Gibson and Dr. Mayer on the Melius team. Their expertise provides invaluable insight into our GEMM™ and its future clinical applications.
https://t.co/wf7fQGEeIz
Melius MicroBiomics is a #biotech company that develops engineered microorganisms designed to be uniquely effective and safe in the treatment of gut-related illnesses in humans and animals, including inflammatory bowel disease.
#guthealth#GEMM#innovation#scicomm#lifescience
Check out our new website upgrade! We’ve added new content to keep you up to date on the company's developments, including facts pages that let you dive deeper into the scientific concepts driving our innovation.
https://t.co/6uGJLaX3nM
Whether you’re a fellow scientist, curious reader, or potential collaborator, this content was built to provide up-to-date information on topics including the #gutmicrobiome#IBD and #probiotics.
Melius’ CSO, Deanna Gibson, was a guest on @CRAMIdeas, where they discussed the story behind our GEMM™ technology, which are super probiotics that thrive in gut inflammation and allow for healing.
You can watch the podcast here: https://t.co/z01f9j5vxp
Melius is at the forefront of a new class of therapies by engineering bacteria designed with the potential to help heal & prevent gut-related illnesses. Built on 10+ years of R&D led by Dr. Gibson, our GEMMs enhance the therapeutic efficacy of beneficial bacteria in the gut.
Our CMO @emeranamayer was named to the list of the world’s most influential scientists! This honour highlights his work in the top 1% of citations worldwide in gastroenterology, neurobiology & microbiome. We are so proud to have his leadership driving Melius forward. #Biotech
We recently submitted a manuscript showcasing exciting preclinical data using our GEMM™ in rodent and pig colitis models. Learn more by exploring our submission to BioRxiv below!
#Melius#Innovation#BioTech#GutHealth
https://t.co/k5urdMqGqs
We are excited to announce that @emeranamayer has joined Melius MicroBiomics as our Chief Medical Officer (CMO). Dr. Mayer will play a crucial role in helping to bring our GEMM™ into humans to promote gut-brain health.
When looking at the development of Inflammatory Bowel Disease in populations around the world, there are 4 distinct stages that are observed. - THREAD 🧵
Info from: Kaplan & Windsor (2021). Nature Reviews Gastroenterology & Hepatology
Probiotic effectiveness relies on cell viability, but many products don't meet their viability claims, reducing their benefits & misleading consumers. At Melius MicroBiomics, we developed an encapsulation method to enhance viability & shelf life. #Probiotics#GutHealth#Melius